A real-world study for polymyxin B in the treatment of carbapenems resistant gram-negative bacilli

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026458

Enrollment

Unknown

Registered

2019-10-11

Start date

2018-10-01

Completion date

Unknown

Last updated

2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious disease of gram-negative bacilli resistant to carbapenems

Interventions

Case series:Polymyxin B was used to treat gram-negative bacilli resistant to carbapenems

Eligibility

Sex/Gender

All

Age

14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=14 years; 2. Patients treated with polymyxin B anti-infection therapy for 7 days at least.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
mortality;Duration of mechanical ventilation;Length of hospitalization in ICU;Infection site;Pathogenic bacterium;Always such confinement;Number of organ failure;Application time of vasoactive drugs;Vital signs;Oxygenation index;APACHE II score;SOFA score;Infusion volume and urine volume;pathogen-causing;blood routine examination;Biochemical indexes;hemagglutination test;procalcitonin;C-Reactive Protein;	—

Measure

Time frame

mortality;Duration of mechanical ventilation;Length of hospitalization in ICU;Infection site;Pathogenic bacterium;Always such confinement;Number of organ failure;Application time of vasoactive drugs;Vital signs;Oxygenation index;APACHE II score;SOFA score;Infusion volume and urine volume;pathogen-causing;blood routine examination;Biochemical indexes;hemagglutination test;procalcitonin;C-Reactive Protein;

—

Countries

China

Contacts

Public ContactSun Tongwen

The First Affiliated Hospital of Zhengzhou University

suntongwen@163.com+86 13838516916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026